Literature DB >> 16421190

Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development.

Renée V Hoch1, Philippe Soriano.   

Abstract

Fibroblast growth factor receptor 1 (Fgfr1) plays pleiotropic roles during embryonic development, but the mechanisms by which this receptor signals in vivo have not previously been elucidated. Biochemical studies have implicated Fgf receptor-specific substrates (Frs2, Frs3) as the principal mediators of Fgfr1 signal transduction to the MAPK and PI3K pathways. To determine the developmental requirements for Fgfr1-Frs signaling, we generated mice (Fgfr1(Delta)Frs/DeltaFrs) in which the Frs2/3-binding site on Fgfr1 is deleted. Fgfr1(Delta)Frs/DeltaFrs embryos die during late embryogenesis, and exhibit defects in neural tube closure and in the development of the tail bud and pharyngeal arches. However, the mutant receptor is able to drive Fgfr1 functions during gastrulation and somitogenesis, and drives normal MAPK responses to Fgf. These findings indicate that Fgfr1 uses distinct signal transduction mechanisms in different developmental contexts, and that some essential functions of this receptor are mediated by Frs-independent signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421190     DOI: 10.1242/dev.02242

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  61 in total

1.  Mammalian Fbh1 is important to restore normal mitotic progression following decatenation stress.

Authors:  Corentin Laulier; Anita Cheng; Nick Huang; Jeremy M Stark
Journal:  DNA Repair (Amst)       Date:  2010-04-24

2.  A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.

Authors:  Andrew Campbell; Brittany Krupp; Jared Bushman; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

3.  Ureteric morphogenesis requires Fgfr1 and Fgfr2/Frs2α signaling in the metanephric mesenchyme.

Authors:  Sunder Sims-Lucas; Valeria Di Giovanni; Caitlin Schaefer; Brian Cusack; Veraragavan P Eswarakumar; Carlton M Bates
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

4.  The PDGF signaling pathway controls multiple steroid-producing lineages.

Authors:  Jennifer Schmahl; Kamran Rizzolo; Philippe Soriano
Journal:  Genes Dev       Date:  2008-12-01       Impact factor: 11.361

Review 5.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

6.  Frs2α and Shp2 signal independently of Gab to mediate FGF signaling in lens development.

Authors:  Hongge Li; Chenqi Tao; Zhigang Cai; Kristina Hertzler-Schaefer; Tamica N Collins; Fen Wang; Gen-Sheng Feng; Noriko Gotoh; Xin Zhang
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

7.  The nucleosome remodeling and deacetylase complex protein CHD4 regulates neural differentiation of mouse embryonic stem cells by down-regulating p53.

Authors:  Akira Hirota; May Nakajima-Koyama; Yuhei Ashida; Eisuke Nishida
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

Review 8.  Receptor tyrosine kinase signaling: regulating neural crest development one phosphate at a time.

Authors:  Katherine A Fantauzzo; Philippe Soriano
Journal:  Curr Top Dev Biol       Date:  2015-01-20       Impact factor: 4.897

9.  Pten loss induces autocrine FGF signaling to promote skin tumorigenesis.

Authors:  Kristina Hertzler-Schaefer; Grinu Mathew; Ally-Khan Somani; Sunil Tholpady; Madhavi P Kadakia; Yiping Chen; Dan F Spandau; Xin Zhang
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

10.  Posterior malformations in Dact1 mutant mice arise through misregulated Vangl2 at the primitive streak.

Authors:  Rowena Suriben; Saul Kivimäe; Daniel A C Fisher; Randall T Moon; Benjamin N R Cheyette
Journal:  Nat Genet       Date:  2009-08-23       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.